Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Siemens Unveils New Chemistry and Immunoassay Systems

Published: Thursday, July 31, 2014
Last Updated: Thursday, July 31, 2014
Bookmark and Share
Company introduces the ADVIA Chemistry XPT and ADVIA Centaur XPT Immunoassay System at AACC 2014.

Siemens Healthcare has introduced the ADVIA Chemistry XPT System and ADVIA Centaur XPT Immunoassay System at the 2014 AACC Annual Meeting and Clinical Lab Expo, Chicago, July 27-31.

The newest in the company’s portfolio of chemistry and immunoassay instruments for the central laboratory, these systems are designed to enable continuous and simple operation, facilitate delivery of high quality, rapid results, and work seamlessly with automation in high-volume laboratories.

“Faced with ever-increasing workload demands, our customers need easy-to-use solutions that enhance workflow and quickly provide the results,” said Franz Walt, CEO, Chemistry, Immunoassay, Automation and Diagnostics IT Business Unit, Diagnostics Division, Siemens Healthcare. “The ADVIA Chemistry XPT System and ADVIA Centaur XPT Immunoassay System are new central laboratory analyzers designed to meet these requirements.”

Each system features versatile technology that will enable a broad range of testing to assist clinicians in disease screening, diagnosing and monitoring. Additionally, easy operation will be supported with harmonized, intuitive software, large touchscreens and Siemens Remote Service diagnostics.

A fast system for the high-volume laboratory with a throughput of up to 2400 tests per hour, the ADVIA Chemistry XPT System achieves predictable turnaround times through a combination of micro-volume technology and aliquot retention.

Sample aliquots are readily available onboard for testing and retesting; there is no need to return the tube to the system. The system also includes VeriSmart Technology, a combination of hardware and software checks to help ensure high-quality results.

The ADVIA Centaur XPT Immunoassay System is designed to process up to 240 tests per hour, upload test definitions on demand, and provide uninterrupted processing even when loading and unloading samples, reagents and supplies. The system is intended to require very little maintenance. Its user interface features powerful, easy-to-use software with extensive data management capabilities, and intelligent software algorithms are designed to support laboratory management of results by automatically providing effective diagnostic testing strategies.

Both systems are automation-ready, and can be connected to Siemens’ Aptio Automation, the company’s latest track-based automation system. They require no additional robotics, and utilize point-in-space technology which allows for sampling directly from the automation track.

Also, the ADVIA Chemistry XPT System and ADVIA Centaur XPT Immunoassay System can be connected to the company’s CentraLink Data Management System, which streamlines workflow across automation, IT and instruments, and Siemens Remote Service (SRS).

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos